BLOGS >

Voices

Archives for January 2013

RSS
Engage with independent insights, opinions, and analysis from an array of leaders in cardiology.
Avatar of Kim

How Insurance Status Affects Treatment for Patients with CAD (30 Jan 2013)

Kim G. Smolderen, PhD, Paul S. Chan, MD, MS, and John Ryan, MD

Does a patient’s insurance status affect a physician’s decision to prescribe evidence-based therapies for CAD?

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: January 28th (29 Jan 2013)

Richard Lehman, BM, BCh, MRCGP

This week’s topics include using hospital readmission as a quality marker and the cardiovascular safety of peginesatide for anemia in patients with CKD.

Avatar of Monika

In REGARDS to Depression, MI, and Death in Patients with CHD (29 Jan 2013)

Monika Safford, MD

Monika Safford discusses the behavioral mechanisms that most contribute to the association between depression and MI or death in those with CHD.

Avatar of Robert

Getting a Read on St. Jude Leads: An Interview with Robert G. Hauser (28 Jan 2013)

Robert George Hauser, BS MD and John Ryan, MD

The researcher and EP who first documented problems with St. Jude next generation leads reacts to the FDA’s recent letter to the company and explains what he is doing for patients who have received these devices.

Avatar of Sarah

Appropriate Use or Defensive Medicine? (25 Jan 2013)

Sarah C. Hull, MD, MBE (Master of Bioethics)

Is the practice of defensive medicine overriding the implementation of appropriate use to the detriment of economics, patient care, and medical education?

Avatar of Anita

Hospital Readmissions May Be Just the Tip of the Iceberg (24 Jan 2013)

Anita Vashi, MD, MPH

Do you know when your patients end up back in the ED but are not rehospitalized?

Avatar of Murray

Renal Denervation: Delineating Its Uses, Misuses, and Possibilities (22 Jan 2013)

Murray David Esler, MBBS PhD and John Ryan, MD

Is Renal Denervation a cure? A likely overused “magic bullet” in patients who should receive more behavior modification and drug treatment? Where exactly should it fit in our arsenal? John Ryan interviews Murray David Esler

Avatar of Eiman

How Will You PROTECT Your Patients with Nonvalvular Afib? (22 Jan 2013)

Eiman Jahangir, MD

For which patients is the Watchman left-atrial appendage closure device a better alternative to warfarin and other anticoagulant medications?

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: January 21st (21 Jan 2013)

Richard Lehman, BM, BCh, MRCGP

This week’s topics include a review of drug-eluting stents and a summary of hypertrophic cardiomyopathy.

Avatar of Harlan M. Krumholz, MD, SM

Media Coverage of Research: Does It Sometimes Miss the Point? (18 Jan 2013)

Harlan M. Krumholz, MD, SM

Observing media coverage of a new study, Harlan Krumholz wonders if the spin misses the point of the research.